Supply Issues Medicareplus International Ltd Barrier Film Products ELY532 ELY533 and ELY788 (ICN 2297)

• The supply issue with Barrier Film products from Medicareplus International Ltd is continuing.
• One further product code is now suspended and unavailable to order, ELY533 – Barrier film foam applicator no sting sterile.
• ELY532 and ELY788 remain available to order on intermittent supply basis and once the available stock is depleted, they will be suspended until stock can be replenished.
• Three product codes are affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 6 November 2023.

Change:

• The supplier Medicareplus International Ltd has informed us of a supply issue with its Barrier Film products.
• There are two product codes affected:
  • ELY532 – Barrier film foam applicator no sting sterile
  • ELY788 – Barrier film wipe no sting non-sterile.
• The supply issue is due to increased demand and lead times.

Impact:          

• All the affected product codes are currently subject to intermittent supply and once the available stock is depleted, they will be suspended until stock can be replenished.
• Potential indirect alternative products are available to order through our online catalogue.
• However, some of these products may also be subject to intermittent supply.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is anticipated to be resolved by 6 November 2023.

Next Steps:              

• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.